VUMC participating in clinical trial of novel heart failure treatment

Vanderbilt University Medical Center is one of roughly 60 study sites worldwide participating in RESPONDER-HF, a randomized clinical trial of an atrial shunt to treat heart failure patients.

Patients with a form of heart failure called HFpEF may breathe normally at rest but quickly become breathless with physical activity. The study will test an atrial shunt to relieve high pressure in the heart.

Brown selected as medical director of Discharge Care Center

Emily Brown, MD, Assistant Professor of Clinical Medicine (General Internal Medicine and Public Health), has been named the medical director of the Vanderbilt University Medical Center Discharge Care Center, an around-the-clock call center comprised of a multidisciplinary team that serves as a centralized resource to aid adult patients navigating the health care system after discharge. Her new role was effective July 1.

Vanderbilt Transplant Center finishes fiscal year with record 809 solid organ transplants

Vanderbilt’s adult heart, lung, liver and kidney transplant programs individually had record fiscal years, with 150 heart transplants, 90 lung transplants, 180 liver transplants and 333 kidney transplants. In addition, adult transplant teams performed three heart/lung transplants and four kidney/pancreas transplants. Heidi Schaefer, MD (Nephrology and Hypertension), is the medical director of Adult Solid Organ Transplant.